| P2093 | author name string | Park J | |
| | Morrow CD | |
| | Wakefield JK | |
| P2860 | cites work | Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of Rous Sarcoma Virus | Q22122431 |
| | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 |
| | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
| | Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 | Q24559906 |
| | Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein | Q24561778 |
| | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release | Q24563651 |
| | Active nuclear import of human immunodeficiency virus type 1 preintegration complexes | Q24564507 |
| | Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 |
| | Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase | Q24629039 |
| | Oligomeric structure of a prototype retrovirus glycoprotein | Q24645144 |
| | Active human immunodeficiency virus protease is required for viral infectivity | Q24647696 |
| | Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A | Q24649411 |
| | Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 | Q27702268 |
| | X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes | Q27703747 |
| | Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein | Q28247468 |
| | Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 |
| | The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 |
| | Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 |
| | Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera | Q48367084 |
| | A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses | Q48367108 |
| | Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes | Q48375100 |
| | Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. | Q48378749 |
| | Sequence-specific RNA binding by the HIV-1 Rev protein | Q50335727 |
| | Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells. | Q55243456 |
| | HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product | Q59048755 |
| | Therapy for human immunodeficiency virus infection | Q40853702 |
| | Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro | Q41258164 |
| | Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. | Q41557849 |
| | HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA | Q41599796 |
| | Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide | Q41674152 |
| | Brain-derived cells contain a specific binding site for Gp120 which is not the CD4 antigen | Q41674966 |
| | Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs | Q41686213 |
| | Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology | Q41689070 |
| | Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene | Q41699910 |
| | Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. | Q41757816 |
| | pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane | Q41764642 |
| | Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases | Q42195585 |
| | Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequences | Q42616376 |
| | A novel gene of HIV-1, vpu, and its 16-kilodalton product | Q42656133 |
| | Purification and characterization of the RNase H domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli | Q43449938 |
| | Plasma viremia in human immunodeficiency virus infection | Q43513599 |
| | Potential metal-binding domains in nucleic acid binding proteins | Q43519683 |
| | Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus | Q43563098 |
| | Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. | Q44219513 |
| | Molecular modeling of the HIV-1 protease and its substrate binding site | Q44324216 |
| | HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 |
| | Ordered interstrand and intrastrand DNA transfer during reverse transcription | Q45058628 |
| | Secondary structure is the major determinant for interaction of HIV rev protein with RNA. | Q45129827 |
| | Nucleotide sequences at host–proviral junctions for mouse mammary tumour virus | Q45802722 |
| | Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins | Q45830218 |
| | Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 |
| | The sor gene of HIV-1 is required for efficient virus transmission in vitro | Q45831189 |
| | Expression and characterization of the trans-activator of HTLV-III/LAV virus | Q45831293 |
| | Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes | Q45831871 |
| | Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy | Q45836320 |
| | Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 |
| | Tat protein from human immunodeficiency virus forms a metal-linked dimer | Q45841752 |
| | Quantitation of human immunodeficiency virus type 1 in the blood of infected persons | Q45844274 |
| | Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys | Q45847056 |
| | The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 |
| | Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. | Q45852163 |
| | Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase | Q45860303 |
| | High-Level Viremia in Adults and Children Infected with Human Immunodeficiency Virus: Relation to Disease Stage and CD4+ Lymphocyte Levels | Q45860605 |
| | A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients | Q46065811 |
| | A nucleoprotein complex mediates the integration of retroviral DNA. | Q46128219 |
| | Characterization of ribosomal frameshifting in HIV-1 gag-pol expression | Q46573916 |
| | Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 |
| | Cellular transcription factors involved in the regulation of HIV-1 gene expression | Q28272528 |
| | The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA | Q28279502 |
| | rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA | Q28279513 |
| | Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus | Q28286288 |
| | Retroviral DNA integration directed by HIV integration protein in vitro | Q28646770 |
| | Correct integration of retroviral DNA in vitro | Q28646811 |
| | Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 | Q28646812 |
| | Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection | Q28646834 |
| | Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor | Q29547710 |
| | Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma | Q29615115 |
| | How eukaryotic transcriptional activators work | Q29618289 |
| | Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA | Q29620616 |
| | Development and early natural history of HTLV-III antibodies in persons with hemophilia. | Q33445031 |
| | Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus | Q33562331 |
| | Integration of human immunodeficiency virus type 1 DNA in vitro | Q33608319 |
| | Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome | Q33649232 |
| | Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity | Q33666234 |
| | Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence | Q33669533 |
| | Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor | Q33681763 |
| | Human immunodeficiency virus type 1 negative factor is a transcriptional silencer | Q33836630 |
| | Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease | Q33843249 |
| | Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration | Q33852223 |
| | Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 |
| | Lipid composition and fluidity of the human immunodeficiency virus | Q34048036 |
| | Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 |
| | Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency | Q34055177 |
| | Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. | Q34161762 |
| | A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 |
| | Identification of a protein encoded by the vpu gene of HIV-1. | Q34163678 |
| | Retroviruses | Q34172442 |
| | A structural model for the retroviral proteases. | Q34173510 |
| | RNA-dependent DNA polymerase in virions of RNA tumour viruses | Q34206460 |
| | Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS | Q34250436 |
| | Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia | Q34252853 |
| | A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia | Q34274580 |
| | Functional role of human immunodeficiency virus type 1 vpu. | Q34288200 |
| | Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 |
| | Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. | Q34323971 |
| | Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor | Q34323995 |
| | Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion | Q34335264 |
| | Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein | Q34349908 |
| | Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. | Q34382153 |
| | Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 |
| | Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase | Q34577497 |
| | Contingent genetic regulatory events in T lymphocyte activation | Q34679681 |
| | The biochemistry of AIDS. | Q34843720 |
| | Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients | Q35597880 |
| | A rapid in vitro assay for HIV DNA integration | Q35763859 |
| | Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells | Q35837431 |
| | HIV regulatory proteins: potential targets for therapeutic intervention | Q35898335 |
| | A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus | Q36355881 |
| | Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses | Q36470925 |
| | Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase | Q37396397 |
| | Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA | Q37402258 |
| | Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 |
| | Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes | Q37476959 |
| | A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene | Q37514563 |
| | Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1 | Q37639095 |
| | Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein | Q37675018 |
| | Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. | Q37690674 |
| | RNA packaging signal of human immunodeficiency virus type 1 | Q38328360 |
| | Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection | Q38328607 |
| | DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2 | Q38334254 |
| | Human immunodeficiency viruses and the pathogenesis of AIDS. | Q38626990 |
| | Protein-mediated membrane fusion | Q38648025 |
| | Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. | Q39090316 |
| | HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain | Q39313963 |
| | Molecular genetics and structure of the human immunodeficiency virus | Q39573787 |
| P433 | issue | 5 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | C1135-56 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | American Journal of Physiology | Q2160146 |
| P1476 | title | Viral gene products and replication of the human immunodeficiency type 1 virus | |
| P478 | volume | 266 | |